ALCON, INC.
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 04, 2017 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 7,500 Total Citation Count
- Dec 21, 1977 Earliest Filing
- 303 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9693967 Biodegradable microparticle pharmaceutical formulations exhibiting improved released ratesSep 07, 05Jul 04, 17[A61K]
9068246 Decarbonization process for carbothermically produced aluminumDec 15, 08Jun 30, 15[C22B, C21C, C21B]
7758778 Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agentsSep 07, 05Jul 20, 10[A61J, B29B]
7261529 Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agentsSep 07, 05Aug 28, 07[B29B]
7111665 Lubricant for improved surface quality of cast aluminum and methodAug 04, 05Sep 26, 06[B22D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7780728 Correction of higher order aberrations in intraocular lensesWithdrawnMay 17, 06Aug 24, 10[A61F]
2010/0199,269 PROGRAM OPTIMIZATION DEVICE AND PROGRAM OPTIMIZATION METHODAbandonedOct 08, 08Aug 05, 10[G06F]
2010/0152,279 RNAi Inhibition of Serum Amyloid A For Treatment of GlaucomaAbandonedFeb 25, 10Jun 17, 10[A61K, A61P]
2009/0258,955 INTRAOCULAR IRRIGATING SOLUTION HAVING IMPROVED FLOW CHARACTERISTICSAbandonedApr 14, 09Oct 15, 09[A61K]
2009/0203,614 USE OF AGENTS THAT PREVENT THE GENERATION OF AMYLOID-LIKE PROTEINS AND/OR DRUSEN, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT THE NEUROTOXIC EFFECTS OF SUCH PROTEINS IN THE TREATMENT OF MACULAR DEGENERATIONAbandonedApr 17, 09Aug 13, 09[A61K, A61P]
2009/0181,893 USE OF AGENTS THAT PREVENT GENERATION OF AMYLOID AND AMYLOID-LIKE LIPOPROTEINS, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT NEUROTOXICITY OF SUCH PROTEINS IN THE TREATMENT OF HEARING LOSS AND IMPROVING BODY BALANCEAbandonedMar 02, 09Jul 16, 09[A61K, A61P]
2009/0181,933 USE OF STEROIDS TO TREAT PERSONS SUFFERING FROM OCULAR DISORDERSAbandonedJan 11, 08Jul 16, 09[A61K]
2009/0160,075 METHODS FOR FABRICATING CUSTOMIZED INTRAOCULAR LENSESAbandonedDec 17, 08Jun 25, 09[A61F, B29D]
2009/0164,008 LENS SURFACE WITH COMBINED DIFFRACTIVE, TORIC, AND ASPHERIC COMPONENTSAbandonedDec 21, 07Jun 25, 09[A61F]
2009/0156,693 OPHTHALMIC COMPOSITIONS CONTAINING POLYSACCHARIDE/BORATE GELLING SYSTEMAbandonedFeb 23, 09Jun 18, 09[A61K, A61P]
2009/0048,146 USE OF AGENTS THAT UPREGULATE CRYSTALLIN EXPRESSION IN THE RETINA AND OPTIC NERVE HEADAbandonedDec 21, 07Feb 19, 09[A61K, C12Q, C12N, G01N]
2009/0018,548 Pneumatically-Powered Intraocular Lens Injection Device with Removable CartridgeAbandonedJul 13, 07Jan 15, 09[A61F]
7476687 Substituted furo[2,3-g]indazoles for the treatment of glaucomaExpiredNov 24, 04Jan 13, 09[A01N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.